Biomarkers in Medicine

Papers
(The TQCC of Biomarkers in Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Systemic immune-inflammation index is a novel marker to predict functionally significant coronary artery stenosis69
Role of hematological parameters in COVID-19 patients in the emergency room69
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-1946
Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review42
The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort42
Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-1935
The diagnostic value of plasma exosomal hsa_circ_0070396 for hepatocellular carcinoma33
Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis29
Systemic immune–inflammation index predicts new-onset atrial fibrillation after ST elevation myocardial infarction24
Neutrophil to lymphocyte ratio as a predictive biomarker for computed tomography scan use in mild traumatic brain injury20
Role of miRNAs as biomarkers of COVID-19: a scoping review of the status and future directions for research in this field19
The prognostic significance of hemoglobin-to-red cell distribution width ratio in muscle-invasive bladder cancer19
Serum aberrant expression of miR-24-3p and its diagnostic value in Alzheimer’s disease18
Identification of a four-microRNA panel in serum as promising biomarker for colorectal carcinoma detection18
Monocyte to high-density lipoprotein cholesterol ratio is associated with the presence of carotid artery disease in acute ischemic stroke17
Novel biomarkers for acute respiratory distress syndrome: genetics, epigenetics and transcriptomics17
Prospective selected biomarkers in COVID-19 diagnosis and treatment16
Prognostic value of hemoglobin-to-red cell distribution width ratio in cancer: a systematic review and meta-analysis16
Circular RNAs: new genetic tools in melanoma16
Cell-free DNA as a solid-organ transplant biomarker: technologies and approaches16
Homocysteine as a marker for predicting disease severity in patients with COVID-1915
Biomarkers in pediatric sepsis: a review of recent literature15
Exosomes as mediators and biomarkers in fibrosis15
How biomarkers can improve pneumonia diagnosis and prognosis: procalcitonin and mid-regional-pro-adrenomedullin14
Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs14
Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectives14
Lymphocyte-to-C-reactive protein ratio is a potential new prognostic biomarker for patients with lung cancer13
HER2 in metastatic colorectal cancer: a new to target to remember13
Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients13
Liquid biopsy: the value of different bodily fluids12
Biomarkers of cholestasis12
FAM3C: an emerging biomarker and potential therapeutic target for cancer12
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer12
Macromolecular biomarkers of chronic obstructive pulmonary disease in exhaled breath condensate12
Red blood cell distribution width as a prognostic biomarker for viral infections: prospects and challenges11
Construction prognosis model based on autophagy-related gene signatures in hepatocellular carcinoma11
Red blood cell distribution width and atrial fibrillation11
MiR-9-5p promotes cell proliferation and migration of hepatocellular carcinoma by targeting CPEB311
Quantitative muscle MRI biomarkers in Duchenne muscular dystrophy: cross-sectional correlations with age and functional tests11
Breast invasive ductal carcinoma diagnosis with a three-miRNA panel in serum10
Sialic acid as a potential biomarker for cardiovascular disease, diabetes and cancer10
Inflammatory markers and incident heart failure in older men: the role of NT-proBNP10
Prognostic nutritional index and systemic immune-inflammation index are prognostic biomarkers for non-small-cell lung cancer brain metastases10
Prognostic value of serum albumin for long-term mortality in patients with dual-chamber permanent pacemakers10
Tubular injury and cell-cycle arrest biomarkers to predict acute kidney injury in noncritically ill children receiving aminoglycosides10
Prognostic value and dynamics of antithyroglobulin antibodies for differentiated thyroid carcinoma10
Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies9
Increased levels of circulating circular RNA (hsa_circ_0013587) may serve as a novel biomarker for pancreatic cancer9
Copeptin: a neuroendocrine biomarker of COVID-19 severity9
Role of collagen turnover biomarkers in the noninvasive assessment of myocardial fibrosis: an update9
ANXA2is a potential marker for the diagnosis of human cervical cancer9
The potential of miR-499 plasmatic level as a biomarker of obstructive sleep apnea syndrome9
The aegis: platelets as biomarkers of tumor progression9
Expression pattern of ALDH1, E-cadherin, Vimentin and Twist in early and late onset sporadic colorectal cancer9
N-glycosylation profiling of Type 2 diabetes mellitus from baseline to follow-up: an observational study in a Ghanaian population9
Neutrophil-to-lymphocyte ratio is prognostic in recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan9
Galectin-3 and acute heart failure: genetic polymorphisms, plasma level, myocardial fibrosis and 1-year outcomes8
Circulating chemerin level and risk of cancer: a systematic review and meta-analysis8
Role of ncRNA in multiple myeloma8
HSP90α combined with AFP and TK1 improved the diagnostic value for hepatocellular carcinoma8
Significance of tumor protein p53 mutation in cellular process and drug selection in brain lower grade (WHO grades II and III) glioma8
Neutrophil to lymphocyte ratio in the prediction of coagulopathy in traumatic brain injury8
Circular RNA as a potential diagnostic and/or therapeutic target for endometriosis8
Urinary tubular biomarkers as predictors of death in critically ill patients with COVID-198
Prognostic value of D-dimer/fibrinogen ratio in the adverse outcomes of patients hospitalized for heart failure8
Prognostic and diagnostic roles of prolyl 4-hydroxylase subunit α members in breast cancer8
NCAPG is a prognostic biomarker of immune infiltration in non-small-cell lung cancer8
Cardiovascular risk assessment and association with novel biomarkers in patients with Type 2 diabetes mellitus8
Association between admission blood fibrinogen-to-albumin ratio and clinical outcomes after acute lacunar stroke8
miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkers8
Circular RNA hsa_circ_0001445 in plasma as a novel biomarker for osteoporosis in postmenopausal women8
Association between D-dimer levels and post-acute sequelae of SARS-CoV-2 in patients from a tertiary care center8
Sex-biased DNA methylation in papillary thyroid cancer8
Biomarkers of human gut microbiota diversity and dysbiosis8
Screening for regenerative therapy responders in heart failure7
Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals7
Safety and disease monitoring biomarkers in Duchenne muscular dystrophy: results from a Phase II trial7
Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience7
COVID-19 and diffusing capacity of the lungs for carbon monoxide: a clinical biomarker in postacute care settings7
Cleavage and polyadenylation-specific factor 3 induces cell cycle arrest via PI3K/Akt/GSK-3β signaling pathways and predicts a negative prognosis in hepatocellular carcinoma7
miRNA 21: a novel biomarker in the treatment of bladder cancer7
Prognostic Nutritional Index and CRP, age, platelet count, albumin level score in predicting mortality and intensive care unit admission for COVID-197
Advances in the discovery of novel biomarkers for cancer: spotlight on protein N-glycosylation7
Osteopontin as novel biomarker for reversibility of pressure overload induced left ventricular hypertrophy7
Long noncoding plasmacytoma variant translocation 1 facilitates the surveillance of acute respiratory distress syndrome and mortality prediction in sepsis7
Perspectives on statistical strategies for the regulatory biomarker qualification process7
CD34+ cells and endothelial progenitor cell subpopulations are associated with cerebral small vessel disease burden7
Circulating levels of clusterin and complement factor H in patients with obstructive sleep apnea7
Urinary proteins detected using modern proteomics intervene in early type 2 diabetic kidney disease – a pilot study6
Serum biomarkers for thyroid cancer6
Novel molecular biomarkers and diagnosis of acute appendicitis in children6
Significance of plasma free fatty acid level for assessing and diagnosing acute myocardial infarction6
Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension6
Serum biomarker CA 15-3 as predictor of response to antifibrotic treatment and survival in idiopathic pulmonary fibrosis6
Can the systemic immune-inflammation index be used as a novel diagnostic tool in the diagnosis of subacute thyroiditis?6
Copy number alteration signatures as biomarkers in cancer: a review6
Role of MMP-2 and its inhibitor TIMP-2 as biomarkers for susceptibility to systemic lupus erythematosus6
Lp-PLA2 as a biomarker and its possible associations with SARS-CoV-2 infection6
Nomogram based on neutrophil-to-platelet ratio to predict in-hospital mortality in infective endocarditis6
Extracellular miRNA biomarkers in neurologic disease: is cerebrospinal fluid helpful?6
iTRAQ-based comparative proteomics analysis reveals specific urinary biomarkers for various kidney diseases6
Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitors6
High expression of DNAJA1 (HDJ2) predicts unfavorable survival outcomes in breast cancer6
National Early Warning Score 2 and laboratory predictors correlate with clinical deterioration in hospitalized patients with COVID-196
Role of plasma angiotensin II and angiotensin-converting enzyme 2 levels on prognosis and mortality in hypertensive patients with COVID-196
Prognostic value of OCT4 in colorectal cancer: analysis using immunohistochemistry and bioinformatics validation6
Association of fibrinogen/albumin ratio and coronary collateral circulation in stable coronary artery disease patients6
Study of confounding factors influence on lung cancer diagnostics effectiveness using gas chromatography–mass spectrometry analysis of exhaled breath6
Bioinformatic identification of prognostic indicators in bladder cancer6
Novel biomarker-based score (SAD-60) for predicting mortality in patients with COVID-19 pneumonia: a multicenter retrospective cohort of 1013 patients6
Circulating PV-1 as a marker of celiac disease-associated liver injury5
Serum HMGB1 and soluble urokinase plasminogen activator receptor levels aid diagnosis and prognosis prediction of sepsis with acute respiratory distress syndrome5
STAT6 correlates with response to immune checkpoint blockade therapy and predicts worse survival in thyroid cancer5
Usefulness of C-reactive protein/albumin ratio as a predictor of new-onset atrial fibrillation in SARS-COV-25
LncRNA NEAT1 correlates with Th1 and Th17 and could serve as an assistant biomarker in sepsis5
AKP and GGT level can provide an early prediction of first-line treatment efficacy in colorectal cancer patients with hepatic metastases5
Serum AMDL DR-70 levels: a new concept in the diagnosis and follow-up of colorectal carcinoma5
Prognostic and predictive value of Pleckstrin homology-like domain, family A family members in breast cancer5
Evaluation of the relation between cardiac biomarkers and thorax computed tomography findings in COVID-19 patients5
Using machine learning method to identify MYLK as a novel marker to predict biochemical recurrence in prostate cancer5
De Ritis ratio: how effectively can we use in bladder cancer management?5
Clinical significance of miR-33b in glioma and its regulatory role in tumor cell proliferation, invasion and migration5
Vitamin D level predicts angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with ST segment elevation myocardial infarction5
Predictive value of a novel lncRNA LINC02518 in evaluating the prognosis of patients with hepatocellular carcinoma5
Application of a machine learning-driven, multibiomarker panel for prediction of incident cardiovascular events in patients with suspected myocardial infarction5
Identification of hub genes and discovery of promising compounds in gastric cancer based on bioinformatics analysis5
Expression of DUSP4 transcript variants as a potential biomarker for colorectal cancer5
Prognostic value of triglyceride/glucose index in patients with ST-segment elevation myocardial infarction5
Elevated expression of FABP4 is associated with disease activity in rheumatoid arthritis patients5
Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study)5
Novel marker for predicting the severity and prognosis of acute pulmonary embolism: platelet-to-hemoglobin ratio5
Urine headspace analysis with field asymmetric ion mobility spectrometry for detection of chronic kidney disease5
Identification of prognosis-associated immune genes and exploration of immune cell infiltration in colorectal cancer5
0.04131293296814